Core Viewpoint - The article discusses the ongoing legal actions against Renzi Hang (任子行) for financial misconduct, including inflated revenue and profit figures, leading to investor claims for compensation [1][2][3]. Group 1: Legal Proceedings - The law firm Shanghai Jiucheng, represented by lawyer Xu Feng, has received a court report on investor loss calculations related to Renzi Hang, with multiple cases already filed in court [1][2]. - The investor compensation cases have partially commenced in court, and the legal team is actively pursuing further claims and accepting new investor mandates [1][2]. Group 2: Financial Misconduct - Renzi Hang was found to have inflated its operating income by amounts of 36,951,333.48 yuan, 48,435,351.70 yuan, and 26,929,607.08 yuan from 2020 to mid-2022, representing 4.21%, 6.97%, and 10.81% of the reported figures respectively [3]. - The company also inflated its total profit by 19,406,901.32 yuan, 37,317,431.71 yuan, and 16,560,909.58 yuan, which accounted for 85.93%, 70.03%, and 30.79% of the absolute values in the respective periods [3]. - Renzi Hang's annual reports for 2020 and 2021, as well as the semi-annual report for 2022, contained false records, and the company referenced these inflated figures in its fundraising documents in February 2023 [3]. Group 3: Investor Compensation Eligibility - Investors who purchased Renzi Hang stock between April 27, 2021, and August 10, 2024, and sold or continued to hold the stock after August 10, 2024, are eligible to initiate claims for compensation [4].

Core Viewpoint - Zhejiang Furun (600070) is facing a lawsuit for investor compensation due to inflated revenue and costs from 2020 to mid-2022, with a court date set for December 8, 2025 [1][2]. Summary by Sections Legal Proceedings - The lawsuit for investor compensation is scheduled to be heard at Shaoxing Intermediate Court on December 8, 2025, with ongoing efforts to accept additional claims from investors [1][2]. - Investors who purchased Zhejiang Furun shares between April 27, 2021, and April 28, 2023, and sold or held the shares after April 28, 2023, are eligible to file claims [6]. Financial Misconduct - From January 2020 to mid-2022, Zhejiang Furun's subsidiary fabricated advertising agency processes, leading to inflated revenue and costs [4][5]. - The total inflated revenue amounted to approximately 717.23 million yuan, while inflated costs totaled about 715.51 million yuan [5]. - Specific years of inflated figures include: - 2020: Revenue inflated by 365.77 million yuan (12.04% of reported revenue) and costs inflated by 364.92 million yuan (13.30%) [5]. - 2021: Revenue inflated by 142.61 million yuan (10.87%) and costs inflated by 143.23 million yuan (11.11%) [5]. - 2022 (first half): Revenue inflated by 208.85 million yuan (69.05%) and costs inflated by 207.35 million yuan (69.79%) [5]. Regulatory Actions - On May 18, 2024, Zhejiang Furun received an administrative penalty decision from the Zhejiang Regulatory Bureau of the CSRC, confirming the existence of the aforementioned illegal activities [3].

投资快报记者 余以墨 广州报道 累计占用总额高达8.84亿元 据公开信息，海德股份资金占用发生的时间可追溯到2021年4月21日。 公开资料显示，海德股份于2021年3月开展不良资产收购重组业务，并陆续向债权交易方支付了债权收 购价款。 海德股份（000567）在2025年11月28日公告称收到证监会下发的《立案通知书》。上海沪紫律师事务所 刘鹏律师表示，受损投资者可以发送联系方式至suopeibao@126.com报名参加索赔预登记。 涉资金占用事项被立案 海德股份在2025年11月28日发布公告称，公司收到中国证监会下发的《立案告知书》。因涉嫌信息披露 违法违规，依据相关法律法规被证监会立案调查。其中提到，因公司及其实控人涉嫌信息披露违法违 规，根据相关法律法规证监会决定对公司及实控人立案。 值得注意的是，海德股份直接在立案公告中坦言存在资金占用问题，公司称这一问题早已存在，已于 2025年4月24日全部归还占用资金，整改完成。 海德股份此次被调查，其实控人同步被立案。与此同时，与海德股份实控人相关的两家上市公司永泰能 源和海伦哲也分别发布公告，强调证监会立案主体是海德股份与其实控人，涉及事项与自身无关。 ...

Core Points - Shenyang Chemical Co., Ltd. received an administrative penalty from the Liaoning Regulatory Bureau of the China Securities Regulatory Commission for falsifying financial data from 2018 to 2021, resulting in a fine of 7 million yuan and warnings to responsible personnel [1] - The company’s subsidiary, Shenyang Wax Chemical, manipulated financial data by adjusting production input quantities and delaying inventory recognition, leading to false reporting in annual reports for four consecutive years [1] - Affected investors who purchased shares between March 21, 2019, and August 9, 2024, may register for compensation through the "Sina Investor Rights Protection Platform" [2][3] Summary by Sections - **Administrative Penalty**: Shenyang Chemical was warned and fined 7 million yuan due to false financial reporting, with key personnel facing market bans of 8 and 4 years [1] - **Investigation Background**: The company was under investigation for information disclosure violations, leading to the issuance of a notice of administrative penalty [1] - **Investor Compensation**: Investors who held shares during the specified period may be eligible for compensation, with the final compensation scope determined by the court [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 2025年11月26日，上海久诚律师事务所许峰律师代理的一批世纪华通（维权）（002602）投资者索赔案 再次获得绍兴市中级人民法院立案，律师团队同步还在推进后续案件的立案工作，还在持续接受其他投 资者的索赔委托。需要特别提示的是，许峰律师代理的部分世纪华通投资者索赔案已获赔到位。（许峰 律师专栏） 世纪华通2025年三季报披露，截至2025年9月30日，共收到79起投资者索赔的立案起诉材料，合计索赔 金额约人民币7，285.51万元，上述案件均已在浙江省绍兴市中级人民法院立案。如后续相关诉讼案件 金额达到披露标准，公司将严格按照相关要求履行信息披露义务。 2024年11月6日，世纪华通公告收到证监会《行政处罚决定书》，经查明，世纪华通违法事实如下： 一、2018-2022年年报商誉有关情况存在虚假记载 （一）2018年未按规定执行商誉减值测试，导致2018年年报少计提商誉减值准备6，236.30万元。 （三）2019-2022年年报报告分部的披露不符合会计准则的规定，未将点点作为单独的报告分部进行披 露。 （四）2020-2022年未按规定执行商誉减值测试， ...

Core Viewpoint - The case of investor compensation against Southern Precision (002553) due to false statements has progressed, with investors set to receive compensation through mediation led by attorney Xu Feng from Shanghai Jiucheng Law Firm [1][2]. Group 1: Legal Developments - Xu Feng has represented multiple investors in the Southern Precision compensation case, which has been filed in court multiple times and continues to accept claims from other investors [1]. - The Jiangsu Securities Regulatory Bureau issued an administrative regulatory measure against Southern Precision on July 10, 2023, due to inaccurate information regarding humanoid robots that led to abnormal stock price fluctuations [1]. Group 2: Investor Compensation Criteria - Investors who purchased Southern Precision stock between June 20, 2023, and July 5, 2023, and sold or continued to hold the stock after July 5, 2023, are eligible to initiate compensation claims [2].

登录新浪财经APP 搜索【信披】查看更多考评等级 2024年8月2日，山东未名生物医药股份有限公司（ST未名（维权），002581）发布《关于收到中国证 券监督管理委员会 <行政处罚决定书> 的公告》。公告显示，公司已于2024年8月1日收到中国证监会出 具的《行政处罚决定书》（〔2024〕3号）。根据《行政处罚决定书》，ST未名及实际控制人之一等因 涉嫌信息披露违法违规，中国证监会已依法调查审理终结，并对公司及相关责任人作出了行政处罚。 近期公司动态 在公告收到证监会《行政处罚决定书》后，ST未名于2025年11月17日发布了《第六届董事会第九次会 议决议公告》。公告显示，公司董事会审议通过了《关于拟变更会计师事务所的议案》、《关于召开 2025年第三次临时股东会的议案》等两项议案。 律师观点与索赔条件 上海百悦律师事务所牛彬律师表示，ST未名因信息披露违法违规已被中国证监会正式行政处罚，受损 投资者可依法提起诉讼索赔。暂定索赔条件为：·于2018年8月22日至2023年11月24日期间买入ST未名 （002581）股票，并且在2023年11月24日收盘后仍持有该股票的受损投资者（最终索赔条件以法院认定 为 ...

Group 1 - The core issue involves investor claims against Aolian Electronics (300585) due to false statements, with ongoing legal actions being pursued by attorney Xu Feng [1][2] - Aolian Electronics received an administrative penalty from the China Securities Regulatory Commission (CSRC) for misleading statements regarding its performance in the perovskite sector, leading to a significant stock price drop of 29.92% over two trading days [1] - The stock price decline of Aolian Electronics was notably higher than the broader market, with a deviation of 28.76 percentage points from the ChiNext Index during the same period [1] Group 2 - Attorney Xu Feng indicates that investors who purchased Aolian Electronics shares between December 12, 2022, and February 21, 2023, may still initiate claims, as the statute of limitations is nearing its end [2] - The law firm is also handling claims for investors of Puli Pharmaceutical (300630), with some cases already in court and awaiting further court arrangements [2] - Puli Pharmaceutical was found to have inflated its revenue and profits through fictitious sales from 2021 to 2022, with significant overstatements in both years [3] Group 3 - Investors who bought Puli Pharmaceutical shares between April 26, 2022, and April 17, 2024, are also eligible to file claims, as per attorney Xu Feng's guidance [4] - The law firm has a history of successfully representing investors in securities fraud cases, with numerous claims currently in progress [4]

Group 1 - The core issue is that Zhuolang Technology has been delisted due to significant violations, including false reporting of financial data from 2019 to 2023, which inflated revenue and profit figures [1] - Zhuolang Technology's subsidiary, Tianjin Zhuolang Technology Development Co., Ltd., falsely reported sales of server, software, and system integration services, resulting in inflated revenues of 249.15 million, 489.13 million, 338.61 million, 656.13 million, and 82.25 million yuan for the respective years, accounting for 21.05%, 45.19%, 41.60%, 72.46%, and 13.22% of reported revenues [1] - The inflated profit figures for the same years were 249.15 million, 309.90 million, 338.61 million, 357.13 million, and 82.25 million yuan, representing 33.81%, 7.68%, 41.26%, 86.08%, and 50.27% of the reported profit totals [1] Group 2 - Zhuolang Technology failed to disclose significant external guarantees, including a contract signed on September 19, 2019, where its subsidiary provided collateral for a loan of 702 million yuan, with the collateral valued at 491 million yuan, which was 71.89% and 14.82% of the audited net assets for 2019 and 2020 respectively [2] - Investors who suffered losses due to false statements can seek compensation under the Securities Law, which includes claims for investment differences, commissions, and stamp duty losses [2] Group 3 - Investors who purchased Zhuolang Technology stock between September 24, 2019, and March 14, 2024, and sold or continued to hold the stock after March 15, 2024, are eligible to initiate claims for compensation [3] Group 4 - The claims process involves contacting a lawyer to register the intention to claim [4] - Required materials include trading records stamped by the securities company, account confirmation documents, and a copy of the ID along with contact information [8][10]

Core Viewpoint - Dongni Electronics has been penalized by the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission for failing to disclose significant contract progress and for false financial reporting, leading to potential investor claims for damages [1][4]. Group 1: Contract Disclosure Issues - Dongni Electronics failed to timely disclose the inability to meet the delivery schedule of a significant contract with Guangdong Tianyu Semiconductor, where only 6.74% of the contracted quantity was delivered by the end of October 2023 [2]. - The contract, signed on January 9, 2023, involved the delivery of 135,000 pieces of 6-inch silicon carbide substrates worth 675 million yuan, which accounted for 51.84% of the company's latest audited main business revenue [1]. Group 2: Financial Reporting Irregularities - The company misclassified research and development expenses, leading to an inflated profit total of 56.81 million yuan in both the 2022 annual report and the 2023 semi-annual report [3]. - Dongni Electronics failed to account for materials procured through a related party, resulting in an additional profit inflation of 27.46 million yuan across the same reporting periods [3]. - The company did not adequately provision for inventory impairment, which inflated profits by 38.77 million yuan in the 2022 annual report and 72.28 million yuan in the 2023 semi-annual report, representing 38.63% and 70.95% of the reported profit amounts, respectively [4].